Bessemer Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Bessemer Group’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-9,000	Closed	-$15K	–	1855
2015 Q2	$15K	Hold	9,000	–	–	﹤0.01%	1180
2015 Q1	$13K	Hold	9,000	–	–	﹤0.01%	1196
2014 Q4	$14K	Hold	9,000	–	–	﹤0.01%	1197
2014 Q3	$19K	Hold	9,000	–	–	﹤0.01%	1018
2014 Q2	$28K	Hold	9,000	–	–	﹤0.01%	971
2014 Q1	$23K	Buy	+9,000	New	+$23K	﹤0.01%	975

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Bessemer Group's RXII Position: Q3 2015 in Review

Bessemer Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2015, closing a stake of 9,000 shares — an estimated $15K sold.

Bessemer Group first reported a position in RXII in Q1 2014 and held it in 6 quarters. The position peaked at $28K in Q2 2014. 78 funds tracked by Wall St. Rank hold RXII as of Q3 2015.

Bessemer Group reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2015 after selling out during the quarter.
Bessemer Group sold 9,000 GALENA BIOPHARMA INC COM shares in Q3 2015, an estimated $15K.
Bessemer Group first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 6 quarters.
Bessemer Group's GALENA BIOPHARMA INC COM position peaked at $28K in Q2 2014.
78 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2015.

Based on Bessemer Group's 13F filing for Q3 2015, filed 16 Nov 2015.